1 study found for:    21343559 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Study of Neoadjuvant Vemurafenib for BRAF Mutant Melanoma and Palpable Lymph Node Metastasis
Condition: Melanoma
Intervention: Drug: Vemurafenib

Indicates status has not been verified in more than two years